Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

The synthesis and the aromatase (CYP19) inhibitory activity of 5-[(aryl)(imidazol-1-yl)methyl]-1H-indoles were reported. Among the tested racemate compounds, 5-[(4-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-indole 8b emerged as a potent CYP19 inhibitor (IC(50)=15.3 nM). Chiral chromatography allowed isolation of the (+) enantiomer 8b2, which was about twice as active as the racemate (IC(50)=9 nM).

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Preparation and pharmacological profile of 7-(α-Azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis of imidazole-derived steroidal hybrids as potent aromatase inhibitors
Medicinal Chemistry Research 2013.0
Synthesis and biological evaluation of imidazolylmethylacridones as cytochrome P-450 enzymes inhibitors
MedChemComm 2012.0
Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy
Medicinal Chemistry Research 2011.0
Design, Synthesis, and Biological Evaluation of Imidazolyl Derivatives of 4,7-Disubstituted Coumarins as Aromatase Inhibitors Selective over 17-α-Hydroxylase/C17−20 Lyase
Journal of Medicinal Chemistry 2011.0
Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Lead optimization of 4-imidazolylflavans: New promising aromatase inhibitors
European Journal of Medicinal Chemistry 2011.0